You asked, we listened! Next month, we are launching a new and improved user profile experience to keep you connected.In the meantime, if you would like to update your profile please contact our office at 507-284-2317 or email us at

Robert Jenkins, M.D., Ph.D. (PATH ’87), Division of Laboratory Genetics and Genomics, Mayo Clinic Rochester

Robert Jenkins, M.D., Ph.D. (PATH ’87), Division of Laboratory Genetics and Genomics at Mayo Clinic in Rochester and a Ting Tsung and Wei Fong Chao Professor in Individualized Medicine Research, co-authored a study that identified the biologic mechanism of a germline alteration that may be critical for developing new therapies to treat and prevent a type of brain tumor. The findings are published in the Oct. 7, 2022, issue of the journal Science, and the results have relevance to other cancers and diseases. The research was led by the Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital, Toronto; Mayo Clinic Comprehensive Cancer Center; and Mayo Clinic Center for Individualized Medicine. Dr. Jenkins is a professor of laboratory medicine and pathology in the Mayo Clinic College of Medicine and Science.

Recommended reading

Posts about similar topics:

Shopping cart0
There are no products in the cart!